Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Publication year range
1.
Nihon Shokakibyo Gakkai Zasshi ; 109(6): 936-43, 2012 Jun.
Article in Japanese | MEDLINE | ID: mdl-22688170

ABSTRACT

A 74-year-old man was admitted to our hospital with abdominal pain and bloody stool. The patients' history showed that he had had occlusion of the proximal common trunk of the celiac artery (CA) and the superior mesenteric artery (SMA). The inferior mesenteric artery (IMA), and the marginal artery of the colon had developed well. It was assumed that almost the entire visceral blood might be supplied by the IMA to the CA and the SMA. Our investigation revealed that the patient had advanced cancer of the sigmoid colon, which had caused intestinal obstruction. Sigmoidectomy was performed with care to avoid injuring the IMA and the marginal arcade artery. Normal hemodynamics were successfully established followed by sigmoidectomy, and cure was obtained in this patient.


Subject(s)
Adenocarcinoma/surgery , Sigmoid Neoplasms/surgery , Aged , Celiac Artery/pathology , Collateral Circulation , Colon, Sigmoid/surgery , Humans , Male , Mesenteric Artery, Superior/pathology
2.
Leuk Lymphoma ; 43(3): 641-3, 2002 Mar.
Article in English | MEDLINE | ID: mdl-12002772

ABSTRACT

A 54-year-old man diagnosed with IgD myeloma (stage IIIA) in complete remission (CR) received peripheral blood stem cell transplantation (PBSCT) twice with an interval of 4 months using high-dose melphalan 200mg/m2. However 9 months after the second PBSCT, he was readmitted because of lumbago, lower left hemiparesis, speech disturbance and left facial nerve palsy. A lumbar puncture revealed myeloma cells in the cerebrospinal fluid (CSF). The patient did not respond to any salvage chemotherapy and died of sepsis 27 months after the initial diagnosis. The findings in this patient suggest that another treatment modality including prophylactic intrathecal injection of an anti-cancer drug as well as allogeneic cell therapy is probably necessary in patients with high-risk IgD myeloma.


Subject(s)
Meningeal Neoplasms/etiology , Multiple Myeloma/pathology , Multiple Myeloma/therapy , Stem Cell Transplantation , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Fatal Outcome , Humans , Immunoglobulin D , Male , Meningeal Neoplasms/diagnosis , Middle Aged , Multiple Myeloma/immunology , Recurrence
SELECTION OF CITATIONS
SEARCH DETAIL
...